AU7947000A - Tricyclic fused-imidazole derivatives - Google Patents
Tricyclic fused-imidazole derivativesInfo
- Publication number
- AU7947000A AU7947000A AU79470/00A AU7947000A AU7947000A AU 7947000 A AU7947000 A AU 7947000A AU 79470/00 A AU79470/00 A AU 79470/00A AU 7947000 A AU7947000 A AU 7947000A AU 7947000 A AU7947000 A AU 7947000A
- Authority
- AU
- Australia
- Prior art keywords
- imidazole derivatives
- tricyclic fused
- tricyclic
- fused
- imidazole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP29521499A JP4409680B2 (en) | 1999-10-18 | 1999-10-18 | Tricyclic fused imidazole derivatives |
JP11/295214 | 1999-10-18 | ||
PCT/JP2000/007201 WO2001029038A1 (en) | 1999-10-18 | 2000-10-18 | Tricyclic fused-imidazole derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
AU7947000A true AU7947000A (en) | 2001-04-30 |
Family
ID=17817687
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU79470/00A Abandoned AU7947000A (en) | 1999-10-18 | 2000-10-18 | Tricyclic fused-imidazole derivatives |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP4409680B2 (en) |
AU (1) | AU7947000A (en) |
WO (1) | WO2001029038A1 (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102006051796A1 (en) * | 2006-11-03 | 2008-05-08 | Merck Patent Gmbh | Triaza-benzo [e] azulene derivatives |
WO2013055793A1 (en) * | 2011-10-12 | 2013-04-18 | University Of Pittsburg-Of The Commonwealth System Of Higher Education | Small molecules targeting androgen receptor nuclear localization and/or level in prostate cancer |
CN102898425B (en) * | 2012-10-30 | 2014-10-08 | 黑龙江八一农垦大学 | 4,5-glyoxalidine [1,2-a] quinoline derivative and application of 4,5- glyoxalidine [1,2-a] quinoline derivative |
CA2912918C (en) * | 2013-06-24 | 2021-07-27 | Merck Patent Gmbh | Imidazole compounds as modulators of fshr and uses thereof |
US20160257657A1 (en) | 2013-09-20 | 2016-09-08 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Small molecule inhibitors of the nuclear translocation of androgen receptor for the treatment of castration-resistant prostate cancer |
JP6564380B2 (en) | 2013-09-20 | 2019-08-21 | ユニバーシティ オブ ピッツバーグ − オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション | Compounds for treating prostate cancer |
US9527835B2 (en) | 2014-02-13 | 2016-12-27 | Incyte Corporation | Cyclopropylamines as LSD1 inhibitors |
AU2015217073B2 (en) | 2014-02-13 | 2019-08-22 | Incyte Holdings Corporation | Cyclopropylamines as LSD1 inhibitors |
HUE045725T2 (en) | 2014-02-13 | 2020-01-28 | Incyte Corp | Cyclopropylamines as lsd1 inhibitors |
EP3392244A1 (en) | 2014-02-13 | 2018-10-24 | Incyte Corporation | Cyclopropylamines as lsd1 inhibitors |
WO2016007727A1 (en) | 2014-07-10 | 2016-01-14 | Incyte Corporation | Triazolopyridines and triazolopyrazines as lsd1 inhibitors |
TWI687419B (en) | 2014-07-10 | 2020-03-11 | 美商英塞特公司 | Imidazopyridines and imidazopyrazines as LSD1 inhibitors |
WO2016007722A1 (en) | 2014-07-10 | 2016-01-14 | Incyte Corporation | Triazolopyridines and triazolopyrazines as lsd1 inhibitors |
WO2016007736A1 (en) | 2014-07-10 | 2016-01-14 | Incyte Corporation | Imidazopyrazines as lsd1 inhibitors |
TWI714567B (en) | 2015-04-03 | 2021-01-01 | 美商英塞特公司 | Heterocyclic compounds as lsd1 inhibitors |
MY189367A (en) | 2015-08-12 | 2022-02-08 | Incyte Corp | Salts of an lsd1 inhibitor |
US10980806B2 (en) | 2016-03-24 | 2021-04-20 | University of Pittsburgh—of the Commonwealth System of Higher Education | Small molecule inhibitors of the nuclear translocation of androgen receptor for the treatment of castration-resistant prostate cancer |
EP3445339B1 (en) | 2016-04-22 | 2023-08-23 | Incyte Corporation | Formulations of an lsd1 inhibitor |
US10968200B2 (en) | 2018-08-31 | 2021-04-06 | Incyte Corporation | Salts of an LSD1 inhibitor and processes for preparing the same |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8422918D0 (en) * | 1984-09-11 | 1984-10-17 | May & Baker Ltd | Compositions of matter |
US5547975A (en) * | 1994-09-20 | 1996-08-20 | Talley; John J. | Benzopyranopyrazolyl derivatives for the treatment of inflammation |
-
1999
- 1999-10-18 JP JP29521499A patent/JP4409680B2/en not_active Expired - Fee Related
-
2000
- 2000-10-18 AU AU79470/00A patent/AU7947000A/en not_active Abandoned
- 2000-10-18 WO PCT/JP2000/007201 patent/WO2001029038A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
JP4409680B2 (en) | 2010-02-03 |
WO2001029038A1 (en) | 2001-04-26 |
JP2001114780A (en) | 2001-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6314900A (en) | Biarylurea derivatives | |
AU6714700A (en) | Cyclopropylindole derivatives | |
AU1173201A (en) | Skin-gripper | |
AU2882801A (en) | Azepine derivatives | |
AU7947000A (en) | Tricyclic fused-imidazole derivatives | |
AU3840000A (en) | Tricyclic compounds | |
AU6014900A (en) | Staurosporin derivatives | |
AU2220801A (en) | Tricyclic compounds and addition salts thereof | |
AU2224901A (en) | Novel phenylalanine derivatives | |
AU7319800A (en) | 4-oxybenzopyran derivative | |
AU7952800A (en) | 2-alkoxybenzene derivatives | |
AU3075800A (en) | Dicarba-(closo)-dodecaborane derivatives | |
AU3670000A (en) | Novel thiazolobenzimidazole derivatives | |
AU5429000A (en) | Novel bicyclonucleoside derivatives | |
AU7453900A (en) | 4-oxybenzopyran derivative | |
AU2001275794A1 (en) | Pyrrole derivatives | |
AU1304801A (en) | Tricyclic azaindolizine derivatives having an SPLA2- inhibiting effect | |
AU6050500A (en) | Benzothiophene derivatives | |
AU4614100A (en) | Cyanobiphenyl derivatives | |
AU6262300A (en) | Indolinylamide derivatives | |
AU1558300A (en) | 1-cycloalkylpyrazoyl-benzoyl derivatives | |
AU5666800A (en) | Difuropyrone derivatives | |
AU2028401A (en) | 3-methyl-chromane or thiochromane derivatives | |
AU6567400A (en) | Substituted 2-imino-thiazolines | |
AU2230101A (en) | Tricyclic compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |